Related Experiment Video
Updated: Apr 18, 2026
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Secondary acute myeloid leukemia arising early after cyclophosphamide treatment
Hayretdin Koklu1, Abdurrahman Tufan, Yusuf Erkul
1Ic Hastaliklari ABD, Gazi Universitesi Hastanesi, 06500, Besevler, Ankara, Turkey, hayretdink@gmail.com.
Background:
Acute myeloid leukemia (AML) can develop secondary to drug treatment. This phenomenon has been placed under the title "Therapy Related Acute Myeloid Leukemias and Myelodysplastic Syndromes" in the WHO classification of AML. Cyclophosphamide, which is used in various malignancies and rheumatological diseases, is an alkylating agent that plays a significant role in therapy related AML.
Case Description:
A patient treated with cyclophosphamide due to vasculitis, subsequently developed AML months after treatment.
Conclusion:
Cyclophosphamide related AML is seen, in most cases, many years after exposure to the drug. The significance of this report lies in the fact that, to our knowledge, this is the most rapidly arising case of cyclophosphamide related AML.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
08:31Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025